Glaucoma

• FDA approval · 2026-04-09
  FDA Approved: COSOPT PF — Supplemental Application (Thea Pharma Inc.)

  The FDA approved a supplemental application for COSOPT PF (dorzolamide hydrochloride and timolol maleate) by Thea Pharma Inc., marking an ad…

• FDA approval · 2026-04-02
  FDA Approved: ACETAZOLAMIDE — Supplemental Application (Lifestar Pharma LLC)

  FDA approved a supplemental application for acetazolamide filed by Lifestar Pharma LLC under the ANDA program. The document does not specify…

• FDA approval · 2026-03-18
  FDA Approved: IOPIDINE 1% — Supplemental Application (Harrow Eye, LLC)

  FDA approved a supplemental application for IOPIDINE 1% (apraclonidine hydrochloride ophthalmic solution) from Harrow Eye, LLC, indicating a…

• FDA approval · 2026-03-17
  FDA Approved: COMBIGAN — Supplemental Application (Allergan, Inc.)

  FDA approved a supplemental application for COMBIGAN (brimonidine tartrate and timolol maleate) submitted by Allergan, Inc.

• FDA approval · 2026-02-25
  FDA Approved: TAFLUPROST OPHTHALMIC — Supplemental Application (Prasco Laboratories)

  FDA approved a supplemental application for tafluprost ophthalmic from Prasco Laboratories, enabling the marketing of a generic tafluprost o…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• FDA approval · 2026-02-09
  FDA Approved: METHAZOLAMIDE — Original Application (Ajanta Pharma USA Inc.)

  FDA approves Ajanta Pharma USA Inc.'s methazolamide under an Original Application (ANDA) for a generic glaucoma treatment.

• EMA approval · 2026-02-05
  EMA Authorised: DuoTrav (travoprost;timolol) — Novartis Europharm Limited

  The EMA authorised DuoTrav, a fixed-dose combination eye drop of travoprost and timolol by Novartis Europharm Limited, for open-angle glauco…

• FDA approval · 2026-01-28
  FDA Approved: YUVEZZI — Original Application (Visus Therapeutics, Inc.)

  The FDA approved YUVEZZI, a fixed-dose combination ophthalmic preparation of carbachol and brimonidine tartrate, under an original NDA from …

• FDA approval · 2026-01-27
  FDA Approved: IDOSE TR — Supplemental Application (Glaukos Corporation)

  FDA approved a supplemental application for IDOSE TR, a travoprost intracameral product from Glaukos Corporation.

• EMA approval · 2026-01-23
  EMA Authorised: Travatan (travoprost) — Novartis Europharm Limited

  EU marketing authorisation granted for Travatan eye drops (travoprost) by Novartis Europharm Limited for glaucoma (open-angle) and ocular hy…

• FDA approval · 2026-01-12
  FDA Approved: ACETAZOLAMIDE — Supplemental Application (Ajanta Pharma USA Inc.)

  FDA approved Ajanta Pharma USA Inc.'s supplemental application for acetazolamide. This action approves changes to the product associated wit…

• FDA approval · 2025-11-21
  FDA Approved: BRIMONIDINE TARTRATE — Supplemental Application (Sandoz Inc)

  FDA approved a supplemental application for BRIMONIDINE TARTRATE submitted by Sandoz Inc.

• FDA approval · 2025-10-09
  FDA Approved: TRAVATAN Z — Supplemental Application (Novartis Pharmaceuticals Corporation)

  The FDA approved a supplemental application for TRAVATAN Z (travoprost) submitted by Novartis Pharmaceuticals Corporation, resulting in chan…

• FDA approval · 2025-10-01
  FDA Approved: DORZOLAMIDE HYDROCHLORIDE OPHTHALMIC SOLUTION — Supplemental Application (Micro Labs Limited)

  FDA approved a supplemental application for dorzolamide hydrochloride ophthalmic solution from Micro Labs Limited.

• FDA approval · 2025-09-18
  FDA Approved: ALPHAGAN P — Supplemental Application (Allergan, Inc.)

  The FDA approved a supplemental application for Alphagan P (brimonidine tartrate) submitted by Allergan, Inc.

• FDA approval · 2025-07-31
  FDA Approved: VIZZ — Original Application (LENZ Therapeutics, Inc.)

  FDA approved VIZZ (aceclidine) from LENZ Therapeutics in an original new drug application.

• FDA approval · 2025-06-17
  FDA Approved: ACETAZOLAMIDE — Original Application (Sagent Pharmaceuticals)

  FDA approved Sagent Pharmaceuticals' Original Application for Acetazolamide, including Acetazolamide and Acetazolamide Sodium formulations.

• FDA approval · 2025-05-30
  FDA Approved: ACETAZOLAMIDE — Original Application (Aurobindo Pharma Limited)

  FDA approved Aurobindo Pharma Limited's original application for a generic acetazolamide product.

• FDA approval · 2025-05-27
  FDA Approved: DORZOLAMIDE AND TIMOLOL — Supplemental Application (Leading Pharma, LLC)

  FDA approval of a supplemental application for the dorzolamide and timolol combination ophthalmic solution from Leading Pharma, LLC.

• FDA approval · 2025-05-20
  FDA Approved: TIMOLOL MALEATE — Supplemental Application (Rising Pharma Holdings, Inc.)

  FDA approved a supplemental application for timolol maleate from Rising Pharma Holdings, Inc., authorizing changes to an existing generic pr…

• FDA approval · 2025-05-16
  FDA Approved: TIMOLOL MALEATE — Supplemental Application (First Nation Group, LLC)

  The FDA approved a supplemental application for TIMOLOL MALEATE from First Nation Group, LLC, authorizing a new generic product on the marke…

• FDA approval · 2025-04-28
  FDA Approved: PILOCARPINE HYDROCHLORIDE OPHTHALMIC — Original Application (Amneal Pharmaceuticals NY LLC)

  The FDA approved the original application for Pilocarpine Hydrochloride Ophthalmic from Amneal Pharmaceuticals NY LLC, providing a generic p…

• FDA approval · 2025-04-25
  FDA Approved: DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE — Supplemental Application (Gland Pharma Limited)

  FDA approved a supplemental application for a generic dorzolamide hydrochloride and timolol maleate eye drop from Gland Pharma Limited. The …

• FDA approval · 2025-03-27
  FDA Approved: DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE OPHTHALMIC SOLUTION — Supplemental Application (Micro Labs Limited)

  FDA approved a supplemental application from Micro Labs Limited for dorzolamide hydrochloride and timolol maleate ophthalmic solution. This …

• FDA approval · 2025-03-17
  FDA Approved: BIMATOPROST — Original Application (Lifestar Pharma LLC)

  FDA approved the original application for Bimatoprost by Lifestar Pharma LLC, granting approval for a generic ophthalmic solution intended t…